Related Experiment Videos
Serum lipid profile and timolol gel
Mayuri B Khamar1, Neha Bhatt, Kalpen Patel
1BJ Medical College, Ahmedabad, New Delhi, India.
Journal of the Indian Medical Association
|November 28, 2002
Summary
Timolol eye drops for glaucoma can negatively affect lipid profiles and increase cardiovascular risks. Switching to timolol gel normalizes lipid profiles and reduces these risks due to decreased systemic absorption.
Area of Science:
- Ophthalmology
- Cardiology
- Pharmacology
Background:
- Topical timolol eye drops are a common glaucoma treatment.
- Systemic absorption of eye drops can lead to adverse effects.
- Glaucoma management requires monitoring cardiovascular risk factors.
Purpose of the Study:
- To evaluate the impact of switching from timolol eye drops to timolol gel on lipid profiles.
- To assess changes in cardiovascular risk factors associated with this medication switch.
Main Methods:
- Observational study comparing patients using timolol eye drops versus timolol gel.
- Analysis of lipid profiles (cholesterol, triglycerides) and cardiovascular risk markers.
- Assessment of systemic absorption differences between the two formulations.
Main Results:
- Timolol eye drops were associated with altered lipid profiles and increased cardiovascular risk.
- Transition to timolol gel resulted in normalization of lipid profiles.
- Timolol gel showed a decrease in cardiovascular risk factors.
Conclusions:
- Timolol gel offers a safer alternative for glaucoma management by minimizing systemic absorption.
- Switching to timolol gel can mitigate cardiovascular risks associated with topical timolol therapy.
- Reduced systemic absorption of timolol gel is key to its improved cardiovascular safety profile.